GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » Change In Working Capital

Bioqual (Bioqual) Change In Working Capital : $-0.86 Mil (TTM As of May. 2018)


View and export this data going back to . Start your Free Trial

What is Bioqual Change In Working Capital?

Bioqual's change in working capital for the quarter that ended in May. 2018 was $-0.86 Mil.

Bioqual's change in working capital for the fiscal year that ended in May. 2018 was $-0.86 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).


Bioqual Change In Working Capital Historical Data

The historical data trend for Bioqual's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual Change In Working Capital Chart

Bioqual Annual Data
Trend May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
Change In Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.85 -0.49 -0.97 0.91 -0.86

Bioqual Semi-Annual Data
May96 May97 May98 May99 May00 May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
Change In Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.85 -0.49 -0.97 0.91 -0.86

Bioqual Change In Working Capital Calculation

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Working Capital for the trailing twelve months (TTM) ended in May. 2018 was $-0.86 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows Fiscal Years EndedJanuary 31,(Amounts in millions)
Cash flows from operating activities: 2014 2013 2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net (566) (614) (796)
Inventories (1,667) (2,759) (3,727)
Accounts payable 531 1,061 2,687
Accrued liabilities 103 271 (935)
Accrued income taxes (1,224) 981 994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioqual Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Bioqual's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioqual (Bioqual) Business Description

Traded in Other Exchanges
N/A
Address
9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
Executives
Williams Frank E Jr other: Communication, See Remarks 2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines